GBP1 and colorectal cancer: GBP1’s tumor-suppressive role in colorectal cancer contrasts with its oncogenic effects in glioblastoma, risking adverse outcomes with broad inhibition—suppressing it might shrink gliomas but spur colorectal tumors, a complexity necessitating tumor-specific precision [16,17,23,67].